{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:22:09Z","timestamp":1787710929312,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012"],"award-info":[{"award-number":["ANR-18-RHUS-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Paraneoplastic neurological syndromes (PNSs) are rare autoimmune diseases that occur in the context of cancer, but the mechanisms leading to immune tolerance breakdown remain unknown. Breast cancers (BCs) associated with Yo-PNS and Ri-PNS show distinct immune and genetic specificities, suggesting that tumour characteristics may contribute to autoimmunity. Herein, we aimed to investigate whether PNS-associated BCs display additional specificities, including stromal and vascular features that have not been systematically assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared 12 BCs associated with Yo-PNS (Yo-BCs) and 10 BCs associated with Ri-PNS (Ri-BCs) with two independent cohorts of non-PNS breast cancer controls (CtrlYo and CtrlRi) using tumour transcriptomic profiling with a targeted 760-gene panel and complementary immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis identified 27 genes commonly differentially expressed in Yo-BCs and Ri-BCs compared with their respective controls, including upregulation of\n                      <jats:italic>FLT4<\/jats:italic>\n                      . Immunohistochemistry confirmed increased podoplanin-positive lymphatic structures in both Yo-BCs and Ri-BCs. In parallel, Yo-BCs showed predominant mesenchymal phenotype and downregulation of genes associated with hypoxia (\n                      <jats:italic>HIF1A<\/jats:italic>\n                      ,\n                      <jats:italic>FLT1<\/jats:italic>\n                      ,\n                      <jats:italic>LDHA<\/jats:italic>\n                      ,\n                      <jats:italic>P4HA2<\/jats:italic>\n                      ) compared with CtrlYo. These features were not present in Ri-BCs when compared with CtrlRi.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings not only highlight subtype-specificities of Yo- and Ri-associated BCs, but also identify lymphangiogenesis as a shared tumour-intrinsic feature that may be part of a cancer-specific context required to initiate or sustain autoimmunity in PNS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02321-9","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:54:13Z","timestamp":1781697253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome"],"prefix":"10.1186","volume":"28","author":[{"given":"Celeste","family":"Nicola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Villagran-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Treilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1331-4549","authenticated-orcid":false,"given":"Valentin","family":"Wucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Desestret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"7","key":"2321_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1212\/WNL.40.7.1085","volume":"40","author":"HF Furneaux","year":"1990","unstructured":"Furneaux HF, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology. 1990;40(7):1085\u201391.","journal-title":"Neurology"},{"issue":"8","key":"2321_CR2","first-page":"2136","volume":"60","author":"JC Darnell","year":"2000","unstructured":"Darnell JC, Albert ML, Darnell RB. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res. 2000;60(8):2136\u20139.","journal-title":"Cancer Res"},{"issue":"6","key":"2321_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066002","volume":"8","author":"TW Eichler","year":"2013","unstructured":"Eichler TW, Totland C, Haugen M, Qvale TH, Mazengia K, Storstein A, et al. CDR2L antibodies: a new player in paraneoplastic cerebellar degeneration. PLoS ONE. 2013;8(6):e66002.","journal-title":"PLoS ONE"},{"issue":"2","key":"2321_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00262-010-0943-9","volume":"60","author":"C Totland","year":"2011","unstructured":"Totland C, Aarskog NK, Eichler TW, Haugen M, N\u00f8stbakken JK, Monstad SE, et al. CDR2 antigen and Yo antibodies. Cancer immunology, immunotherapy\u202f: CII. 2011;60(2):283\u20139.","journal-title":"Cancer immunology, immunotherapy : CII"},{"issue":"4","key":"2321_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","volume":"11","author":"RJ Buckanovich","year":"1993","unstructured":"Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron. 1993;11(4):657\u201372.","journal-title":"Neuron"},{"key":"2321_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000699","author":"C Simard","year":"2020","unstructured":"Simard C, Vogrig A, Joubert B, Mu\u00f1iz-Castrillo S, Picard G, Rogemond V, et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol Neuroinflamm. 2020. https:\/\/doi.org\/10.1212\/NXI.0000000000000699.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2321_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200015","author":"E Peter","year":"2022","unstructured":"Peter E, Treilleux I, Wucher V, Jougla E, Vogrig A, Pissaloux D, et al. Immune and genetic signatures of breast carcinomas triggering Anti-Yo-associated paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2022. https:\/\/doi.org\/10.1212\/NXI.0000000000200015.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"2321_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-019-05180-5","volume":"175","author":"C van Dooijeweert","year":"2019","unstructured":"van Dooijeweert C, Deckers IAG, Baas IO, van der Wall E, van Diest PJ. Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands. Breast Cancer Res Treat. 2019;175(2):487\u201397.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2321_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200367","volume":"12","author":"E Peter","year":"2025","unstructured":"Peter E, Treilleux I, Wucher V, Villagr\u00e1n-Garc\u00eda M, Dumez P, Pissaloux D, et al. Breast cancer specificities of patients with anti-Ri paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2025;12(2):e200367.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"2321_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10585-021-10120-z","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis. 2022;39(1):159\u201379.","journal-title":"Clin Exp Metastasis"},{"key":"2321_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-4598-7-23","volume":"7","author":"GH Cunnick","year":"2008","unstructured":"Cunnick GH, Jiang WG, Douglas-Jones T, Watkins G, Gomez KF, Morgan MJ, et al. Lymphangiogenesis and lymph node metastasis in breast cancer. Mol Cancer. 2008;7:23.","journal-title":"Mol Cancer"},{"key":"2321_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3389\/fimmu.2019.00720","volume":"10","author":"L Garnier","year":"2019","unstructured":"Garnier L, Gkountidi AO, Hugues S. Tumor-associated lymphatic vessel features and immunomodulatory functions. Front Immunol. 2019;10:720.","journal-title":"Front Immunol"},{"key":"2321_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041169","author":"H Deng","year":"2023","unstructured":"Deng H, Zhang J, Wu F, Wei F, Han W, Xu X, et al. Current status of lymphangiogenesis: molecular mechanism, immune tolerance, and application prospect. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15041169.","journal-title":"Cancers"},{"issue":"10","key":"2321_CR14","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.5858\/2009-0114-OA.1","volume":"134","author":"H Kitano","year":"2010","unstructured":"Kitano H, Kageyama S, Hewitt SM, Hayashi R, Doki Y, Ozaki Y, et al. Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch Pathol Lab Med. 2010;134(10):1520\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"20","key":"2321_CR15","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.18632\/oncotarget.4018","volume":"6","author":"T Kimura","year":"2015","unstructured":"Kimura T, Sugaya M, Oka T, Blauvelt A, Okochi H, Sato S. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation. Oncotarget. 2015;6(20):18081\u201393.","journal-title":"Oncotarget"},{"issue":"9","key":"2321_CR16","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Investig. 2016;126(9):3389\u2013402.","journal-title":"J Clin Investig"},{"issue":"8","key":"2321_CR17","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1093\/brain\/awac088","volume":"145","author":"A Al-Diwani","year":"2022","unstructured":"Al-Diwani A, Theorell J, Damato V, Bull J, McGlashan N, Green E, et al. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis. Brain. 2022;145(8):2742\u201354.","journal-title":"Brain"},{"issue":"4","key":"2321_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","volume":"135","author":"M Small","year":"2018","unstructured":"Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, et al. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018;135(4):569\u201379.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2321_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab185","volume":"3","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, P\u00e9ricart S, Pinto AL, Rogemond V, Mu\u00f1iz-Castrillo S, Picard G, et al. Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis. Brain Commun. 2021;3(3):fcab185.","journal-title":"Brain Commun"},{"issue":"5","key":"2321_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad247","volume":"5","author":"M Villagr\u00e1n-Garc\u00eda","year":"2023","unstructured":"Villagr\u00e1n-Garc\u00eda M, Farina A, Mu\u00f1iz-Castrillo S, Wucher V, Dhairi M, Timestit N, et al. Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis. Brain Commun. 2023;5(5):fcad247.","journal-title":"Brain Commun"},{"issue":"6","key":"2321_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325.","journal-title":"Nat Rev Cancer"},{"key":"2321_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00491","volume":"7","author":"NH Ruddle","year":"2016","unstructured":"Ruddle NH. High endothelial venules and lymphatic vessels in tertiary lymphoid organs: characteristics, functions, and regulation. Front Immunol. 2016;7:491.","journal-title":"Front Immunol"},{"issue":"20","key":"2321_CR23","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","volume":"71","author":"L de Chaisemartin","year":"2011","unstructured":"de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res. 2011;71(20):6391\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"2321_CR24","first-page":"132","volume":"35","author":"PD Ndiaye","year":"2019","unstructured":"Ndiaye PD, Pag\u00e8s G. [VEGF-C and lymphatic vessels: a double-edged sword in tumor development and metastasis]. Med Sci Paris. 2019;35(2):132\u20137.","journal-title":"Med Sci Paris"},{"issue":"2","key":"2321_CR25","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.18632\/oncotarget.13752","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhang D, Yi S, Gong M, Lu C, Cai Y, et al. The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(2):2863\u201373.","journal-title":"Oncotarget"},{"issue":"Pt 6","key":"2321_CR26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Re\u00f1e R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain: A J Neurol. 2001;124(Pt 6):1138\u201348.","journal-title":"Brain: A J Neurol"},{"issue":"5","key":"2321_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.molonc.2015.12.006","volume":"10","author":"R Ganesan","year":"2016","unstructured":"Ganesan R, Mallets E, Gomez-Cambronero J. The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion. Mol Oncol. 2016;10(5):663\u201376.","journal-title":"Mol Oncol"},{"issue":"4","key":"2321_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"2","key":"2321_CR29","first-page":"830","volume":"7","author":"SE Egan","year":"1987","unstructured":"Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, et al. Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1\/2 and NIH 3T3 cells. Mol Cell Biol. 1987;7(2):830\u20137.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2321_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1128\/MCB.01024-07","volume":"28","author":"M Baumgartner","year":"2008","unstructured":"Baumgartner M, Radziwill G, Lorger M, Weiss A, Moelling K. c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site. Mol Cell Biol. 2008;28(2):642\u201355.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2321_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00750-x","volume":"19","author":"MA Ortiz","year":"2021","unstructured":"Ortiz MA, Mikhailova T, Li X, Porter BA, Bah A, Kotula L. Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition. Cell Commun Signal. 2021;19(1):67.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2321_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11\u201320.","journal-title":"Cell Metab"},{"key":"2321_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010028","author":"K Ohshima","year":"2021","unstructured":"Ohshima K, Morii E. Metabolic reprogramming of cancer cells during tumor progression and metastasis. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11010028.","journal-title":"Metabolites"},{"key":"2321_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110151","volume":"87","author":"D Singh","year":"2021","unstructured":"Singh D, Deshmukh RK, Das A. SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells. Cell Signal. 2021;87:110151.","journal-title":"Cell Signal"},{"key":"2321_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2020.05.012","volume":"487","author":"RY Hapke","year":"2020","unstructured":"Hapke RY, Haake SM. Hypoxia-induced epithelial to mesenchymal transition in cancer. Cancer Lett. 2020;487:10\u201320.","journal-title":"Cancer Lett"},{"issue":"63","key":"2321_CR36","doi-asserted-by":"publisher","first-page":"32191","DOI":"10.18632\/oncotarget.25891","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Mirza S, Wu S, Zeng J, Shi W, Band H, et al. 3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition. Oncotarget. 2018;9(63):32191\u2013203.","journal-title":"Oncotarget"},{"key":"2321_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413376","author":"H Zhong","year":"2024","unstructured":"Zhong H, Zhou Z, Wang H, Wang R, Shen K, Huang R, et al. The biological roles and clinical applications of the PI3K\/AKT pathway in targeted therapy resistance in HER2-Positive breast cancer: a comprehensive review. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252413376.","journal-title":"Int J Mol Sci"},{"issue":"32","key":"2321_CR38","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1038\/onc.2015.489","volume":"35","author":"S Ingthorsson","year":"2016","unstructured":"Ingthorsson S, Andersen K, Hilmarsdottir B, Maelandsmo GM, Magnusson MK, Gudjonsson T. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. Oncogene. 2016;35(32):4244\u201355.","journal-title":"Oncogene"},{"issue":"6","key":"2321_CR39","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/bjc.2015.29","volume":"112","author":"M Ricciardi","year":"2015","unstructured":"Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M, et al. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer. 2015;112(6):1067\u201375.","journal-title":"Br J Cancer"},{"issue":"5","key":"2321_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen J, Chen F, He C, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014;25(5):605\u201320.","journal-title":"Cancer Cell"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02321-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:06:20Z","timestamp":1787709980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2321"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02321-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is part of the project Gene PNS (NCT03963700) and was approved by the institutional review board of the\n                      Hospices Civils de Lyon\n                      . Tumours and other biological samples were collected after patients gave informed and written consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"148"}}